IRIS
TRIESTE, LEOPOLDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.284
EU - Europa 5.157
AS - Asia 4.348
SA - Sud America 880
AF - Africa 119
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 20
Totale 17.849
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.980
SG - Singapore 1.650
IT - Italia 1.470
RU - Federazione Russa 1.195
CN - Cina 1.081
GB - Regno Unito 729
BR - Brasile 677
VN - Vietnam 624
DE - Germania 436
UA - Ucraina 286
HK - Hong Kong 231
CA - Canada 219
FR - Francia 187
KR - Corea 161
DK - Danimarca 147
IN - India 136
NL - Olanda 108
SE - Svezia 106
FI - Finlandia 94
AR - Argentina 78
IE - Irlanda 73
PL - Polonia 66
BD - Bangladesh 63
MX - Messico 61
ES - Italia 60
JP - Giappone 58
TR - Turchia 56
ZA - Sudafrica 46
ID - Indonesia 42
EC - Ecuador 41
AU - Australia 36
BE - Belgio 34
IQ - Iraq 32
PH - Filippine 31
AT - Austria 30
PK - Pakistan 30
CO - Colombia 25
PT - Portogallo 22
MY - Malesia 21
CH - Svizzera 20
EU - Europa 20
IL - Israele 19
TW - Taiwan 19
LT - Lituania 15
TN - Tunisia 15
MA - Marocco 14
PY - Paraguay 14
RO - Romania 14
SA - Arabia Saudita 12
UZ - Uzbekistan 12
VE - Venezuela 12
CL - Cile 11
JO - Giordania 11
PE - Perù 11
SK - Slovacchia (Repubblica Slovacca) 10
KE - Kenya 8
AZ - Azerbaigian 7
SN - Senegal 7
AL - Albania 6
BG - Bulgaria 6
EG - Egitto 6
GR - Grecia 6
LV - Lettonia 6
SY - Repubblica araba siriana 6
BY - Bielorussia 5
CY - Cipro 5
DO - Repubblica Dominicana 5
IR - Iran 5
LU - Lussemburgo 5
NP - Nepal 5
NZ - Nuova Zelanda 5
OM - Oman 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
JM - Giamaica 4
KZ - Kazakistan 4
SI - Slovenia 4
UY - Uruguay 4
AO - Angola 3
BO - Bolivia 3
DM - Dominica 3
HN - Honduras 3
HU - Ungheria 3
PS - Palestinian Territory 3
SR - Suriname 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
ET - Etiopia 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
LY - Libia 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
Totale 17.829
Salva come PNG Salva come JPEG
Città #
Dallas 1.853
Singapore 918
Ashburn 502
San Jose 434
Beijing 418
Chandler 375
Woodbridge 342
Southend 341
Houston 268
Pisa 218
Hong Kong 215
Moscow 185
San Mateo 175
Ann Arbor 170
Ho Chi Minh City 169
The Dalles 156
Jacksonville 142
Los Angeles 142
Fairfield 123
Hanoi 119
New York 111
Dearborn 105
Seattle 98
Daejeon 97
Rome 95
Cambridge 90
Wilmington 89
Boardman 88
Falls Church 87
Milan 85
São Paulo 80
Hefei 77
Beauharnois 70
Lauterbourg 69
Santa Clara 69
Dublin 66
Dong Ket 65
Seoul 62
Stevenage 61
Portsmouth 59
Warsaw 58
Lawrence 55
Orem 54
Brooklyn 49
Fremont 49
Montreal 48
Denver 46
Florence 43
Tokyo 43
Buffalo 42
Chennai 42
London 41
Munich 41
Stockholm 38
Salerno 37
Atlanta 36
Council Bluffs 34
Helsinki 33
Bologna 31
Serra 31
Johannesburg 30
Poplar 30
Haiphong 28
Mexico City 28
Paris 27
Frankfurt am Main 26
Buti 25
Montréal 25
Phoenix 25
Amsterdam 24
Chicago 24
Redwood City 23
Ankara 22
Old Bridge 21
Lucca 20
Nuremberg 20
Boston 19
Ottawa 19
Genoa 17
Rio de Janeiro 17
Toronto 17
Da Nang 16
San Francisco 16
Dhaka 15
Guayaquil 15
Livorno 15
Mumbai 15
Querétaro 15
Quito 15
Trento 15
Vienna 15
Hamburg 14
Istanbul 14
Manchester 14
Tel Aviv 14
Charlotte 12
Taipei 12
Turku 12
Xi'an 12
Biên Hòa 11
Totale 10.493
Salva come PNG Salva come JPEG
Nome #
Nutri-Score and Food Perception: Insights from an Italian Study 745
On Robots and Insurance 570
Food literacy and food choice – a survey-based psychometric profiling of consumer behaviour 483
The Effect of using Serifs in Brand Names on Luxury Perception 440
The Evaluative, Economic, and Organizational Dimensions of Personalized Medicine 394
Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study 362
The strength of Nutriscore in improving sustainable eating habits and well-being: bad and good news 345
An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps): Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases 325
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) 318
A systematic literature review of the economic impact of ankylosing spondylitis 303
How colour saturation accelerates purchase behaviour, and influences food choice: 295
Why effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence its adoption? 291
Is EEG Suitable for Marketing Research? A Systematic Review 289
Comparison of generic, condition-specific and mapped health state utility values for pediatric asthma 283
How to design a business model for technology-driven innovations like robots. The case of Robot-Era 280
The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet 276
Natural and man-made disasters: challenges and international perspectives for insurance 274
Approaching 2014: Is Telemedicine Assessed from The Social Perspective? A Brief 2013 Systematic Review 268
Development of an objective feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement 267
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives 267
Different strategies for latent TB assessment in patients undergoing anti-TNF treatment: an economic model 265
Assessing the value of the use of diagnostic technology: trade offs for GPs 265
Cost for Tuberculosis Care in Developed Countries: Which Data for an Economic Evaluation? 258
Which indicators for measuring the daily physical activity? An overview on the challenges and technology limits for Telehealth applications 254
Are drug procurement procedure and award criteria in EU hospital setting standardized and do they take into account effective supply quality? 252
WEB SURVEY AND FOCUS GROUPS EXPLORING KNOWLEDGE, NEEDS AND EXPECTATIONS AMONG SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: PRELIMINARY RESULTS 248
The RaDiCEA Project: cost of illness (COI) analysis applied to Cryopyrin Associated Periodic Syndromes (CAPS) 242
Health information technologies in systemic lupus erythematosus: focus on patient assessment 239
Asessment And Simulation of Costs And QOL For Sublingual Immunotherapy In Paediatric Asthma Vs Placebo: Preliminary Data 239
Columbus' egg and the engineer's effect in forecasting solutions adoption 238
The cost-effectiveness of diagnostic cardiac imaging for stable coronary artery disease 238
Conseguenze cliniche ed economiche dello switch ai biosimilari dell’Infliximab nei pazienti reumatologici in Toscana 235
KNOWLEDGE, USE AND DESIDERATA ABOUT INFORMATION AND COMMUNICATION TECHNOLOGIES SYSTEMS FOR SYSTEMIC LUPUS ERYTHEMATOSUS. PRELIMINARY RESULTS FROM THE INTEGRATE PILOT PROJECT 235
The influence of parental Dietary Behaviors, food literacy and chronotype on Children’s eating habits and psychometric factors 230
Management and Treatment of Type 1 And 2 Diabetes: State of Art 230
Being a caregiver of a Behçet’s syndrome patient: challenges and perspectives during a complex journey 230
Systemic vasculitis: how little we know about their societal and economic burden 229
RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks 225
Taste Your Consumer Audience. How Sensory Expertise Influences Food Choice 223
TABLET TOSCANA to Develop Innovative Organizational Models for Tele-Rehabilitation in Subjects with Congenital and Acquired Developmental Disabilities: A Wait-List Control Group Trial Protocol 222
Consideration on the Accuracy of Watch for Physical Activity Tracker 220
Raiders of Lost Value 217
The definition of a new organizational, technology-based, integrated home care model 216
P56 Early Health Technology Assessment to Guide Introduction of Novel Technology into the Market: The Vostars System Case Study 210
Food literacy and food purchase behaviour 207
The economic impact of gout: a systematic literature review 206
The cost of illness of ultra-rare Cryopyrin Associated Periodic Syndromes (CAPS) in Italy: Preliminary results from the Radicea project 204
Cost analysis of technological vs. conventional upper limb rehabilitation for patients with neurological disorders: an Italian real-world data case study 199
Switching from infliximab‐originator to infliximab‐biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 198
Razionale e strumenti della valutazione economica in sanità 196
Natura e ruolo degli indicatori nella logistica farmaceutica 194
The nature, causes, and effects of skepticism on technology diffusion 180
Rehabilitation with and Without Robot and Allied Digital Technologies (RADTs) in Stroke Patients: A Study Protocol for a Multicentre Randomised Controlled Trial on the Effectiveness, Acceptability, Usability, and Economic-Organisational Sustainability of RADTs from Subacute to Chronic Phase (STROKEFIT4) 179
Innovazione tecnologica, dinamica del contesto economico e logistica in sanità 177
Farmaci per le patologie autoimmuni. Traiettorie di trattamento nell’artrite reumatoide 176
L’evoluzione della distribuzione del farmaco e dell'erogazione dei servizi in farmacia 176
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients’ care pathway 175
Telemonitoring in Cystic Fibrosis: A 4-year Assessment and Simulation for the Next 6 Years 172
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 166
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 165
Finanziamenti pubblici 162
Le start up 159
Strumenti per favorire gli investimenti e la competitività delle imprese 156
Valutazione dei risultati di una gara 156
Analysis and Synthesis in Information Processing and Knowledge Creation 155
The organizational dimension in rare and complex diseases care management: an application of RarERN Path© methodology in ataxias, dystonia and phenylketonuria 154
EYE ON PACK. Visual search strategies in food choice 153
Propedeutica alle scienze Sperimentali. Introduzione al metodo scientifico e all'inferenza statistica. 146
State of the art and future directions in assessing the quality of life in rare and complex connective tissue and musculoskeletal diseases 141
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 139
Valutazione dell’attività di malattia nei periodi di interruzione del trattamento con farmaci biologici modificanti la malattia reumatica in pazienti con artrite reumatoide 138
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 127
Industria 4.0 e Digitalizzazione 117
Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study 106
null 63
Managing customization, brand consistency, and identity dynamic trade-offs: opportunities and chaos 62
Validazione degli algoritmi di selezione dei pazienti reumatologici nei database amministrativi toscani e traiettorie di aderenza ai farmaci biologici modificanti la malattia nell’artrite reumatoide 61
Nonlinear trade-offs in customer acquisition and retention 51
null 13
Totale 17.964
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.365
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.365
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021369 0 0 0 0 0 0 0 0 0 72 133 164
2021/2022745 23 141 29 50 9 15 96 159 56 70 31 66
2022/2023841 65 85 46 134 100 136 10 47 122 28 36 32
2023/2024465 43 18 61 22 18 62 51 38 7 26 29 90
2024/20253.729 66 86 245 184 272 264 565 871 307 171 467 231
2025/20268.455 504 1.192 1.623 1.203 1.001 594 1.003 405 503 427 0 0
Totale 17.964